Tushar D. Nichakawade

Also affiliated with Johns Hopkins University, Johns Hopkins Medicine, Lustgarten Foundation, Sidney Kimmel Comprehensive Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers”.

TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers

Nature(2024)10.1038/s41586-024-07233-2

N/A

0DataRank · unranked

44 citations

Jiaxin Ge, Brian J. Mog, Bum Seok Lee, Alexander H. Pearlman, Michael S. Hwang +22 more

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities

Science Translational Medicine(2024)10.1126/scitranslmed.adg7123

N/A

0DataRank · unranked

25 citations

Nikita Marcou, Sarah R. DiNapoli, Alexander H. Pearlman, Tushar D. Nichakawade, Michael S. Hwang +19 more

TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers

Nature Cancer(2025)10.1038/s43018-025-01069-z

N/A

0DataRank · unranked

2 citations

Joshua Urban, Sarah R. DiNapoli, Bum Seok Lee, Taha Ahmedna, Tushar D. Nichakawade +26 more